5-methylcytosine has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babaya, N; Hiromine, Y; Ikegami, H; Niwano, F; Noso, S; Taketomo, Y; Yoshida, S | 1 |
| Cui, L; Ettela, A; Karakose, E; Stefan-Lifshitz, M; Tomer, Y; Yi, Z; Zhang, W | 1 |
2 other study(ies) available for 5-methylcytosine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Metabolic signatures of β-cell destruction in type 1 diabetes.
Topics: 5-Methylcytosine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Metabolome; Metabolomics | 2023 |
Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.
Topics: 5-Methylcytosine; Animals; Cell Line; Cytokines; Diabetes Mellitus, Type 1; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Exoribonucleases; Female; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Interferon-alpha; Mice; Mice, Inbred NOD; Mice, Transgenic; MicroRNAs; Microtubule-Associated Proteins; Proto-Oncogene Proteins; T-Lymphocytes; Up-Regulation | 2019 |